ArticleAntibiotics (Basel, Switzerland)2024

Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections.

Ute Chiriac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.